Last reviewed · How we verify
Analgesic, Opioid
Analgesic, Opioid is a Opioid analgesic Small molecule drug developed by Virgilio Paolo Carnielli. It is currently FDA-approved for Moderate to severe pain (acute and chronic).
Opioid analgesics bind to opioid receptors in the central and peripheral nervous system to reduce pain perception and transmission.
Opioid analgesics bind to opioid receptors in the central and peripheral nervous system to reduce pain perception and transmission. Used for Moderate to severe pain (acute and chronic).
At a glance
| Generic name | Analgesic, Opioid |
|---|---|
| Sponsor | Virgilio Paolo Carnielli |
| Drug class | Opioid analgesic |
| Target | Opioid receptors (mu, delta, kappa) |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | FDA-approved |
Mechanism of action
Opioids work by activating mu, delta, and kappa opioid receptors, which are G-protein coupled receptors found throughout the brain, spinal cord, and peripheral tissues. This activation inhibits the release of neurotransmitters involved in pain signaling and modulates descending pain pathways, resulting in analgesia. The drugs also produce euphoria and sedation through effects on reward and arousal centers.
Approved indications
- Moderate to severe pain (acute and chronic)
Common side effects
- Constipation
- Nausea
- Drowsiness
- Dizziness
- Respiratory depression
- Physical dependence
Key clinical trials
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Management of Pain in Lumbar Arthrodesis (PHASE4)
- Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
- Compared Reversed US-Guided Dorsal Penile Nerve Block (RUSDPNB) With DPNB in Circumcisions for Pediatric Patients (NA)
- The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster (NA)
- Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum (NA)
- Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy (PHASE4)
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Analgesic, Opioid CI brief — competitive landscape report
- Analgesic, Opioid updates RSS · CI watch RSS
- Virgilio Paolo Carnielli portfolio CI
Frequently asked questions about Analgesic, Opioid
What is Analgesic, Opioid?
How does Analgesic, Opioid work?
What is Analgesic, Opioid used for?
Who makes Analgesic, Opioid?
What drug class is Analgesic, Opioid in?
What development phase is Analgesic, Opioid in?
What are the side effects of Analgesic, Opioid?
What does Analgesic, Opioid target?
Related
- Drug class: All Opioid analgesic drugs
- Target: All drugs targeting Opioid receptors (mu, delta, kappa)
- Manufacturer: Virgilio Paolo Carnielli — full pipeline
- Therapeutic area: All drugs in Pain management
- Indication: Drugs for Moderate to severe pain (acute and chronic)
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing